WHI-P180

CAS No. 211555-08-7

WHI-P180 ( Janex 3 )

Catalog No. M13366 CAS No. 211555-08-7

WHI-P180 is a potent EGFR and Cdk2 inhibitors with IC50 of 4.0 and 1.0 uM, respectively.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 51 In Stock
5MG 85 In Stock
10MG 124 In Stock
25MG 210 In Stock
50MG 311 In Stock
100MG 461 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    WHI-P180
  • Note
    Research use only, not for human use.
  • Brief Description
    WHI-P180 is a potent EGFR and Cdk2 inhibitors with IC50 of 4.0 and 1.0 uM, respectively.
  • Description
    WHI-P180 is a potent EGFR and Cdk2 inhibitors with IC50 of 4.0 and 1.0 uM, respectively.
  • Synonyms
    Janex 3
  • Pathway
    Angiogenesis
  • Target
    CDK
  • Recptor
    CDK2; EGFR
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    211555-08-7
  • Formula Weight
    297.31
  • Molecular Formula
    C16H15N3O3
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    OC1=CC=CC(NC2=C3C=C(OC)C(OC)=CC3=NC=N2)=C1
  • Chemical Name
    3-[(6,7-dimethoxyquinazolin-4-yl)amino]phenol

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.An R, et al. Pharm Res. 2009 Feb;26(2):449-58.
molnova catalog
related products
  • Senexin-A

    A selective inhibitor of CDK8 (IC50=0.28 uM) and CDK19; inhibits CDK8 and CDK19 ATP site binding with Kd50 of 0.83 uM and 0.31 uM, respectively.

  • Roniciclib

    A novel potent, orally active, pan-CDK inhibitor with IC50 of 7/9/11 nM for CDK1/2/4 respectively, inhibits transcriptional CDK9/7 with IC50 of 5-25 nM.

  • CGP-74514A hydrochlo...

    CGP-74514A hydrochloride is a potent CDK1 inhibitor with IC50 of 25 nM; induces caspase-9 activation and PARP degradation, mediates apoptosis in U937 cells.